Table 1.
The Pearson correlation between continuous glucose monitoring metrics and glycemic biomarkers on chronic kidney disease (number of participants)
|
CKD stages
|
1-2
|
3a
|
3b
|
4
|
5
|
Ref.
|
| HbA1c | 0.576 (64) | 0.266 (56) | 0.266 (56) | 0.296 (36) | 0.296 (36) | Lu et al[17] |
| 0.68 (33) | 0.52 (43) | 0.22 (14) | Ling et al[18] | |||
| 0.79 (14) | 0.79 (14) | 0.34 (29) | 0.34 (29) | Lo et al[19] | ||
| 0.38 (25) | 0.38 (25) | Vos et al[20] | ||||
| 0.78 (80) | 0.78 (80) | 0.78 (80) | 0.78 (80) | Zelnick et al[12] | ||
| Glycated albumin | 0.54 (25) | 0.54 (25) | Vos et al[20] | |||
| Fructosamine | 0.78 (80) | 0.78 (80) | 0.78 (80) | 0.78 (80) | Zelnick et al[12] | |
| 0.71 (80) | 0.71 (80) | 0.71 (80) | 0.71 (80) | Zelnick et al[12] |
CKD: Chronic kidney disease; HbA1c: Hemoglobin A1c.